B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
TLDR
In this article, a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), plasma concentrations in patients with coronavirus disease 2019 (COVID-19) was conducted.Abstract:
Alterations in cardiac biomarkers have been reported in patients with coronavirus disease 2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) plasma concentrations in COVID-19. We searched PubMed, Web of Science, and Scopus, between January 2020 and 2021, for studies reporting BNP/NT-proBNP concentrations, measures of COVID-19 severity, and survival status (PROSPERO registration number: CRD42021239190). Forty-four studies in 18,856 COVID-19 patients were included in the meta-analysis and meta-regression. In pooled results, BNP/NT-proBNP concentrations were significantly higher in patients with high severity or non-survivor status when compared to patients with low severity or survivor status during follow up (SMD = 1.07, 95% CI: 0.89-1.24, and p < 0.001). We observed extreme between-study heterogeneity (I 2 = 93.9%, p < 0.001). In sensitivity analysis, the magnitude and the direction of the effect size were not substantially modified after sequentially removing individual studies and re-assessing the pooled estimates, (effect size range, 0.99 - 1.10). No publication bias was observed with the Begg's (p = 0.26) and Egger's (p = 0.40) t-tests. In meta-regression analysis, the SMD was significantly and positively associated with D-dimer (t = 2.22, p = 0.03), myoglobin (t = 2.40, p = 0.04), LDH (t = 2.38, p = 0.02), and procalcitonin (t = 2.56, p = 0.01) concentrations. Therefore, higher BNP/NT-proBNP plasma concentrations were significantly associated with severe disease and mortality in COVID-19 patients.read more
Citations
More filters
Journal ArticleDOI
COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond
Meg Fraser,Arianne Clare Agdamag,V. Maharaj,M. Mutschler,Victoria Charpentier,Mohammed S. Chowdhury,Tamas Alexy +6 more
TL;DR: The incidence, potential mechanisms, blood and imaging tests that can be used to detect the disease, and a brief update on the proposed mechanisms of myocarditis in COVID-19 vaccine recipients are included.
Journal ArticleDOI
Acute and Chronic Effects of COVID-19 on the Cardiovascular System.
Victor Arévalos,Victor Arévalos,Luis Ortega-Paz,Luis Ortega-Paz,Juan José Rodríguez-Arias,Juan José Rodríguez-Arias,Margarita Calvo López,Leticia Castrillo-Golvano,Anthony Salazar-Rodriguez,Marta Sabaté-Tormos,Francesco Spione,Manel Sabaté,Manel Sabaté,Salvatore Brugaletta,Salvatore Brugaletta +14 more
TL;DR: In this article, the authors found that myocardial injury defined by the rise of cardiac biomarkers in blood has been found in multiple studies with a prevalence of about 20% and its presence is related to worse clinical outcomes and in-hospital mortality.
Journal ArticleDOI
Predicting COVID-19 outcomes from clinical and laboratory parameters in an intensive care facility during the second wave of the pandemic in South Africa
Brian W. Allwood,Coenraad F.N. Koegelenberg,Veranyuy D. Ngah,Lovemore N. Sigwadhi,Elvis M Irusen,U Lalla,Anteneh Yalew,Jacques Lukenze Tamuzi,Marli Mc Allister,Annalise E Zemlin,Thumeka P. Jalavu,Rajiv T Erasmus,Zivanai C. Chapanduka,Tandi E. Matsha,I. Fwemba,Alimuddin Zumla,Peter Nyasulu +16 more
TL;DR: The second wave of coronavirus disease 2019 (COVID-19) in South Africa was caused by the Beta variant of severe acute respiratory syndrome coronavirurus-2 as discussed by the authors .
Journal ArticleDOI
Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas
Alberto Palazzuoli,Marco Metra,Sean P. Collins,Marianna Adamo,Andrew P. Ambrosy,Laura Antohi,Tuvia Ben Gal,Dimitrios Farmakis,Finn Gustafsson,Loreena Hill,Yuri Lopatin,Francesco Tramonte,Alexander R. Lyon,Josep Masip,Òscar Miró,Brenda Moura,Wilfried Mullens,Razvan I. Radu,Magdy Abdelhamid,Stefan D. Anker,Ovidiu Chioncel +20 more
TL;DR: Recent advances regarding the relationships between HF and COVID-19 pandemic with respect to epidemiology, pathogenetic mechanisms, and differential diagnosis are examined.
Journal ArticleDOI
Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination: A Pragmatic Narrative Review to Guide Clinical Practice
TL;DR: A review of the current available evidence and guidelines and a summary of the risks and potential use of cardiac investigations and monitoring for patients with COVID-19 is provided in this paper .
References
More filters
Journal ArticleDOI
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati,Douglas G. Altman,Jennifer Tetzlaff,Cynthia D. Mulrow,Peter C Gøtzsche,John P. A. Ioannidis,Mike Clarke,Mike Clarke,Philip J. Devereaux,Jos Kleijnen,David Moher +10 more
TL;DR: An Explanation and Elaboration of the PRISMA Statement is presented and updated guidelines for the reporting of systematic reviews and meta-analyses are presented.
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati,Douglas G. Altman,Jennifer Tetzlaff,Cynthia D. Mulrow,Peter C Gøtzsche,John P. A. Ioannidis,Mike Clarke,Philip J. Devereaux,Jos Kleijnen,David Moher +9 more
TL;DR: The meaning and rationale for each checklist item is explained, and an example of good reporting is included and, where possible, references to relevant empirical studies and methodological literature are included.
Journal ArticleDOI
Operating characteristics of a rank correlation test for publication bias.
TL;DR: In this paper, an adjusted rank correlation test is proposed as a technique for identifying publication bias in a meta-analysis, and its operating characteristics are evaluated via simulations, and the test statistic is a direct statistical analogue of the popular funnel-graph.